Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Diapharm
Diapharm
Activities:
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Regulatory
Diapharm authorised to assist medical device registration in Switzerland
Procedural changes were made in May 2021 in relation to the marketing and distribution of medical devices in Switzerland
Regulatory
Diapharm becomes European Authorised Representative
Companies based outside the EU that want to market their products in it must appoint a representative. Diapharm has been certified as such for medical devices
Pharmaceutical
Diapharm Analytics joins the Tentamus Group
The pharmaceutical laboratory Diapharm Analytics GmbH in Oldenburg, Germany, is joining the Tentamus Group
Research & Development
Diapharm opens new Netherlands branch
The company will bring quality assurance, pharmacovigilance and regulatory affairs services to the Benelux region
Regulatory
Bert Verhage appointed Manager of new Diapharm BV
Regulatory
Dr Ursel Nait joins regulatory specialist Diapharm
She has been named Senior Manager GMP Services at the German firm
Finance
SU BioMedicine and Diapharm collaborate to register and market high quality Chinese medicines in Europe
New venture will support the unmet medical/societal need for cure and care products for personalised health strategies
Subscribe now